PHOSPHOTOPE
LOE ApproachingNDAINJECTION, ORALSOLUTION
Approved
May 1957
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed Yesterday · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PHOSPHOTOPE is a diagnostic radiopharmaceutical administered via injection or oral route as a solution, approved in 1957 by Bracco. The specific mechanism of action and clinical indication remain proprietary or unclear from available data. This legacy product operates in the nuclear medicine/diagnostic imaging space.
LOE Approaching
As a legacy diagnostic product approaching loss of exclusivity with minimal current linked job activity, commercial teams are likely small and focused on managed decline or niche market retention.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
PHOSPHOTOPE offers minimal near-term career growth opportunity; roles are primarily defensive (compliance, manufacturing continuity, regulatory maintenance). Career value derives from managing legacy assets, optimizing manufacturing, and navigating regulatory/reimbursement compliance in niche diagnostic markets.
Regulatory Affairs SpecialistManufacturing/Supply Chain Manager
Worked on PHOSPHOTOPE at Bracco? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.